Clinical trial
The Effect of Red Light Photobiomodulation and Topical Disinfectants on the Nasal Microbiome
NCT05797818 is registered in ClinicalTrials.gov with Ondine Biomedical Inc. as lead sponsor.
Search trials, sites, companies and investigators, and follow each one to the others. Individual plan, $249/seat/mo. Card required.
Registry record
As filed in ClinicalTrials.gov.
- Title
- The Effect of Red Light Photobiomodulation and Topical Disinfectants on the Nasal Microbiome
- Lead sponsor
- Ondine Biomedical Inc.
- Phase
- Phase 1/2
- Overall status
- Completed
- Start date
- January 10, 2023
- Completion date
- February 8, 2023
- Enrollment
- 28 (actual)
- Sites
- 1
Conditions
As the registry lists them; a condition with its own page is linked.
healthcare associated infection, nosocomial infection, surgical site infection